Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 3Breast Neoplasms 3Pancreatic Adenocarcinoma 2Stomatitis 1Radiation Fibrosis Syndrome 1Peripheral Nervous System Diseases 1Neuroma, Acoustic 1Neoplasms 1Inflammation 1Hypertension 1Glioblastoma 1Fibrosis 1Fallopian Tube Neoplasms 1Coronavirus Infections 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Camurati-Engelmann Syndrome 1COVID-19 1Brain Neoplasms 1

Interventions

Glutamine 2sagopilone 1nicotinamide-beta-riboside 1allantoicase 1Vitamin D 1Vitamin B 6 1Vitamin B 12 1Taxoids 1Tadalafil 1Sirolimus 1Prednisolone 1Paclitaxel 1Minocycline 1Metformin 1Losartan 1Hydroxychloroquine 1G(M1) Ganglioside 1Fatty Acids, Omega-3 1Exercise 1Everolimus 1Etoricoxib 1Ethosuximide 1Epoetin Alfa 1Dietary Supplements 1Dexamethasone 1Cryotherapy 1Bortezomib 1BID protein, human 1Acupuncture Therapy 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Peripheral Nervous System Diseases × Losartan × Clear all
NCT06135493 2025-04-24

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Future University in Egypt

Phase 2 Completed
84 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡